APA (7th ed.) Citation

Tanoy Sarkar, Sakib M. Moinuddin, Ayman Isbatan, Jiwang Chen, David Mann, & Fakhrul Ahsan. (2023). Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil and/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension. MDPI AG.

Chicago Style (17th ed.) Citation

Tanoy Sarkar, Sakib M. Moinuddin, Ayman Isbatan, Jiwang Chen, David Mann, and Fakhrul Ahsan. Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil And/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension. MDPI AG, 2023.

MLA (9th ed.) Citation

Tanoy Sarkar, et al. Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil And/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension. MDPI AG, 2023.